| Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate WH Chen, SM Chag, MV Poongavanam, AB Biter, EA Ewere, W Rezende, ... Journal of pharmaceutical sciences 106 (8), 1961-1970, 2017 | 113 | 2017 |
| Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine DK Mathias, JL Plieskatt, JS Armistead, JM Bethony, KB Abdul-Majid, ... Infection and immunity 80 (4), 1606-1614, 2012 | 59 | 2012 |
| Schistosoma mansoni venom allergen-like protein 4 (SmVAL4) is a novel lipid-binding SCP/TAPS protein that lacks the prototypical CAP motifs A Kelleher, R Darwiche, WC Rezende, LP Farias, LCC Leite, R Schneiter, ... Acta Crystallographica Section D: Biological Crystallography 70 (8), 2186-2196, 2014 | 45 | 2014 |
| Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: A vaccine candidate for human … E Curti, C Kwityn, B Zhan, P Gillespie, J Brelsford, V Deumic, J Plieskatt, ... Human vaccines & immunotherapeutics 9 (11), 2342-2350, 2013 | 43 | 2013 |
| Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human … CA Seid, E Curti, RM Jones, E Hudspeth, W Rezende, J Pollet, L Center, ... Human Vaccines & Immunotherapeutics 11 (6), 1474-1488, 2015 | 37 | 2015 |
| Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant … E Curti, CA Seid, E Hudspeth, L Center, W Rezende, J Pollet, C Kwityn, ... Human Vaccines & Immunotherapeutics 10 (7), 1914-1925, 2014 | 36 | 2014 |
| Structural and biochemical analyses of alanine racemase from the multidrug-resistant Clostridium difficile strain 630 OA Asojo, SK Nelson, S Mootien, Y Lee, WC Rezende, DA Hyman, ... Acta Crystallographica Section D: Biological Crystallography 70 (7), 1922-1933, 2014 | 30 | 2014 |
| Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal … W Cheng, E Curti, WC Rezende, C Kwityn, B Zhan, P Gillespie, J Plieskatt, ... Human vaccines & immunotherapeutics 9 (11), 2351-2361, 2013 | 21 | 2013 |
| Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies J Plieskatt, W Rezende, C Olsen, J Trefethen, SB Joshi, CR Middaugh, ... Human Vaccines & Immunotherapeutics 8 (6), 765-776, 2012 | 14 | 2012 |
| Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis OA Asojo, A Kelleher, Z Liu, J Pollet, EM Hudspeth, WC Rezende, ... PLoS neglected tropical diseases 11 (3), e0005374, 2017 | 13 | 2017 |
| Profile of respiratory syncytial virus prefusogenic fusion protein nanoparticle vaccine BN Blunck, W Rezende, PA Piedra Expert Review of Vaccines 20 (4), 351-364, 2021 | 10 | 2021 |
| Design and applications of bifunctional small molecules in biology SR Boyd, L Chang, W Rezende, IO Raji, P Kandel, SL Holmes, ... Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1869 (1), 140534, 2021 | 5 | 2021 |
| The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent W Rezende, X Ye, LS Angelo, AF Carisey, V Avadhanula, PA Piedra Journal of Virology 97 (5), e00254-23, 2023 | 3 | 2023 |
| The RSV F p27 peptide: Current knowledge, important questions W Rezende, HE Neal, RE Dutch, PA Piedra Frontiers in Microbiology 14, 1219846, 2023 | 2 | 2023 |
| The efficiency of p27 peptide cleavage during in vitro respiratory syncytial virus (RSV) infection is cell line and RSV subtype dependent W Rezende, X Ye, LS Angelo, A Carisey, V Avadhanula, PA Piedra bioRxiv, 2022.10. 17.512554, 2022 | 1 | 2022 |
| A simple fluorescence-based assay for quantification of the Toll-Like Receptor agonist E6020 in vaccine formulations J Pollet, L Versteeg, W Rezende, U Strych, F Gusovsky, PJ Hotez, ... Vaccine 35 (10), 1410-1416, 2017 | 1 | 2017 |
| Section D A Kelleher, R Darwiche, WC Rezende, LP Farias, LCC Leite, R Schneiter, ... Acta Cryst 500, 70, 2014 | | 2014 |
| a.(2014) A Kelleher, R Darwiche, WC Rezende, LP Farias, LCC Leite, R Schneiter, ... Schistosoma mansoni, 2186-2196, 0 | | |
